The Hydrus® Microstent is a revolutionary canal-based minimally invasive glaucoma surgery (MIGS) device for adult patients with primary open-angle glaucoma. In these articles, leading European surgeons discuss the device's features and benefits, evaluate its safety and efficacy, and share surgical tips for using it.
Retina experts share their thoughts on how EYLEA 8 mg provides better, faster, and longer drying, its applicability for all eligible treatment-naïve patients, and how the treatment has the potential to shape the future clinical practice.